JFL Life Sciences Ltd
Incorporated in 2010, JFL Life Sciences Ltd produces and markets a wide range of formulations[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Revenue from Operations Growth percentage ・Standalone data |
|
|||
| Trade Receivable Turnover Ratio ratio ・Standalone data |
||||
| Number of New Pharma Products Launched (Domestic) number ・Standalone data |
||||
| Specific Order: J D Healthcare (Pharma Supply) INR Crores ・Standalone data |
||||
| Specific Order: Phil Capital Trading Solutions Inc (International Capsule Manufacturing) USD Millions ・Standalone data |
||||
| Total Permanent Employees number ・Standalone data |
||||
Extracted by Screener AI
Documents
Announcements
-
Copy of Newspaper Publication
30 May 2026 - Published audited financial results for quarter and year ended 31 March 2026 on 30 May 2026.
-
Appointment
29 May 2026 - JFL Life Sciences appoints Mr. Jignesh Sharma as internal auditor for FY2026-27 on May 29, 2026.
-
Updates
29 May 2026 - Board approved audited FY26 results, unmodified audit opinion, appointed internal auditor, and filed related party transactions.
-
Outcome of Board Meeting
29 May 2026 - Board approved FY26 audited results, unmodified audit opinion, and appointed internal auditor for FY27.
-
Structural Digital Database
13 April 2026 - FY26 structured digital database certificate filed; 8 events captured, 5 delayed.
Business Overview:[1]
JFLLSL is a WHO-GMP Certified pharmaceutical company that manufactures and sells products across multiple markets. It specializes in Dry Powder Injectable Solid Oral Dosage Forms (Beta-Lactam & General)